July 2018 Issue Table Of Contents

From The Editor

• What Will The Next 10 Years Bring For Biopharma?

Feature Articles

• Sage Therapeutics — Sitting On The Brink Of CNS Breakthroughs
• Dermatology — A Growth Opportunity For Those Willing To Risk Colossal Failure
• Aurinia: Teamwork Twice

Capitol Perspectives

• Medicare Advantage: The Solution To Value-Based Care

CEO Corner

• Patients And Biopharma: Trusted Partners In Fighting Rare Diseases

From Principles and Policy to Execution

• From Managing Disease, To Providing Patients Superior Quality Of Life

Industry Research

• What Are The Largest Slices Of The 2018 CRO Market?

Inside The Industry

• What Makes It So Hard To Select A CMO?
• Speedy & Profound Culture Change Through Self-Enrollment
• Building New Business Models To Support Cell And Gene Therapy R&D
• Why A Spin-off Is A Win-Win For Big Pharma And Startups
• Recent Changes May Reshape Financial Reporting In The Life Sciences Industry
• A Medical Device Innovator’s Long Road To Success

Leadership Lessons

• Could Innovation Proficiency Improve Biopharma’s Broken Image?

Ask The Board

• What Is Your Opinion On Smaller Rare Disease Companies Being Acquired And Big Pharma’s Ability To Be Patient-Centric With These Populations?
• How Will Pharma Sponsors Comply With PDUFA VI Requirements Related To Collecting/Submitting “Voice Of The Patient” Data As Part Of Their NDA?
• When First Becoming A CEO, What Did You Soon Discover About Yourself As Being A Skill Gap, And How Did You Go About Filling It?